A murine model of neonatal diabetes mellitus in Glis3-deficient mice

FEBS Lett. 2009 Jun 18;583(12):2108-13. doi: 10.1016/j.febslet.2009.05.039. Epub 2009 May 28.

Abstract

Glis3 is a member of the Gli-similar subfamily. GLIS3 mutations in humans lead to neonatal diabetes, hypothyroidism, and cystic kidney disease. We generated Glis3-deficient mice by gene-targeting. The Glis3(-/-) mice had significant increases in the basal blood sugar level during the first few days after birth. The high levels of blood sugar are attributed to a decrease in the Insulin mRNA level in the pancreas that is caused by impaired islet development and the subsequent impairment of Insulin-producing cell formation. The pancreatic phenotypes indicate that the Glis3-deficient mice are a model for GLIS3 mutation and diabetes mellitus in humans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Base Sequence
  • Blood Glucose / metabolism
  • Carboxypeptidases A / metabolism
  • DNA Primers / genetics
  • DNA-Binding Proteins
  • Diabetes Mellitus, Type 1 / genetics*
  • Diabetes Mellitus, Type 1 / metabolism*
  • Diabetes Mellitus, Type 1 / pathology
  • Disease Models, Animal
  • Humans
  • Infant, Newborn
  • Insulin / genetics
  • Islets of Langerhans / metabolism
  • Islets of Langerhans / pathology
  • Mice
  • Mice, Knockout
  • Mutation
  • Pancreas / metabolism
  • Pancreas / pathology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Repressor Proteins / genetics
  • Trans-Activators / deficiency*
  • Trans-Activators / genetics
  • Transcription Factors / deficiency
  • Transcription Factors / genetics

Substances

  • Blood Glucose
  • DNA Primers
  • DNA-Binding Proteins
  • GLIS3 protein, human
  • Glis3 protein, mouse
  • Insulin
  • RNA, Messenger
  • Repressor Proteins
  • Trans-Activators
  • Transcription Factors
  • Carboxypeptidases A